Navigation

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)
Together with its partners, SurgMark is now preparing to conduct clinical studies in North America and Europe and is building its distribution network. (Picture: Gorodenkoff/Adobe Stock)

SurgMark: FDA 510(k) Clearance for SchurSign Tissue Marker

In January SurgMark GmbH announced that the U.S. Food & Drug Administration (FDA) has issued a 510(k) premarket notification for ...

Read more …
The surgical team prepares for an upcoming operation.
The 5-person SurgMark team has already developed several surgical and wound healing products and achieved approvals as Class III medical devices in the U.S. and Europe – and is now on the verge of FDA approval with SchurSign®. (Image: © stock.adobe.com/Syda Productions)

Medtech start-up SurgMark aims to enter the US market

 In breast imaging, doctors mark suspicious areas with marker clips. With SchurSign®, the Hamburg-based medical technology start-up SurgMark has developed an innovative tissue marker made ...

Read more …
Job board